Testing better electrode placement for heart rhythm shock
Part of Heart & circulation clinical trials.
This study tests whether two different positions of the electrodes (pads) used for an electrical shock work equally well for people with atrial fibrillation or flutter. It may help improve how safely and effectively the shock restores a normal rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult and can give consent for the study
- You are scheduled for a planned (non-emergency) electrical shock to treat atrial fibrillation or atrial flutter
- Your blood-thinning medicine plan is enough for the planned cardioversion, per Canadian guidelines
- You must have had a transesophageal echocardiogram (a probe ultrasound through the throat) to check for a blood clot in the heart
- Your skin and body structure allow electrode placement in either the front-left (anterolateral) or front-center (anteroposterior) areas, with no major wounds or skin problems there
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a heart rhythm procedure (cardioversion) affects quality of life in people with persistent atrial fibrillation (AF). It may help you understand whether a specific approach can improve day-to-day symptoms and well-being after treatment.
This trial tests whether using a specific “shock energy” during electrical cardioversion works safely and effectively for people with persistent atrial fibrillation. You might be eligible if your cardioversion is planned (not an emergency) and your doctors determine you can safely take blood thinners.
This study looks at whether giving an electrical shock (cardioversion) right after heart surgery can help people with long-lasting atrial fibrillation keep a normal heartbeat. It may help guide future treatment decisions for patients who have not gotten better with medication.
This trial tests a special defibrillation technique that uses two shocks to reset the heart's rhythm in people with persistent atrial fibrillation. It aims to help patients regain a normal heartbeat without the need for more invasive procedures.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.